Skip to main content
Figure 1 | BMC Endocrine Disorders

Figure 1

From: “Vitamin D supplementation and bone health in adults with diabetic nephropathy: the protocol for a randomized controlled trial”

Figure 1

Study design 1 . 1Abbreviations: Northern Alberta Renal Program (NARP); Alberta Health Services (AHS); randomized controlled trial (RCT); micrograms (mcg); Body mass index (BMI); Dual X-ray absorptiometry (DXA); Bone mineral density (BMD); Hemoglobin A1c (HbA1c); random blood glucose (RBG); estimated glomerular filtration rate (eGFR); 25-hydroxy vitamin D (25(OH)D); 1,25-dihydroxy vitamin D (1,25(OH)2D); alkaline phosphatase (ALP); osteocalcin (OC); bone-specific alkaline phosphatase (BAP); N-telopeptide of type 1 collagen (NTx); fibroblast growth factor-23 (FGF-23).

Back to article page